FDA
-
-
-
-
-
-
-
Caribou Biosciences reports durable responses for CB-011 therapy
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU) following Q4 results
-
-
-
-
-
-
-
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
-
-
-
-
-
-
-
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
-
-
-
-
-
-
-
Caribou Bioscience (CRBU) Announces FDA Clearance of IND in Lupus
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


